bioRxivCancer BiologyPreprint
The metabolic enzyme EXT1 is sufficient to induce the epithelial-mesenchymal transition program in cancers
B. Solaimuthu, A. Khatib, A. Hayashi, M. Tanna, M. Lichtenstein, A. Karmi, Y. D. Shaul
Abstract
Carcinomas often exhibit aggressive characteristics, such as enhanced migration abilities, through the execution of the epithelial-mesenchymal transition (EMT) program. Heparan sulfate (HS) is a polysaccharide expressed on the surface of aggressive cancer cells, which acts as a co-receptor to stimulate EMT-associated signaling pathways. However, despite HS role in cancer aggressiveness, the mechanisms governing its EMT-dependent biosynthesis remains poorly understood. Here, we characterized the HS chain elongation enzyme, exostosin glycosyltransferase 1 (EXT1), as an essential component of the EMT program. We identified an EMT-dependent expression of EXT1 and its selective upregulation in aggressive tumor subtypes and cell lines. Overexpression of EXT1 in epithelial cells is sufficient to induce HS biosynthesis, cell migration, and invasion, form tumors in mice, and activate the STAT3 pathway. Moreover, its knockout in aggressive cells significantly inhibited their EMT-associated characteristics. These findings demonstrate a cellular mechanism by which metabolic processes regulate signaling pathways to govern cell state.
- organism: human
- assay: proteomics
- assay: metabolomics
- research focus: cancer & tumor microenvironment
- research focus: cell signaling & trafficking
- research focus: development & morphogenesis
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- HSD11β1 promotes EMT-mediated breast cancer metastasis
J. Nakayama, T. Ishikawa, … H. Makinoshima·bioRxiv·Sep 27, 2021
- Quantifying the patterns of metabolic plasticity and heterogeneity along the epithelial-hybrid-mesenchymal spectrum in cancer
S. Muralidharan, S. Sahoo, … M. K. Jolly·bioRxiv·Dec 18, 2021
- Decoding the coupled decision-making of the epithelial-mesenchymal transition and metabolic reprogramming in cancer
M. L. Galbraith, H. L. Levine, … D. Jia·bioRxiv·Aug 2, 2022
- ETS1 Orchestrates a Hybrid EMT Program Driving in vivo Metastasis and Immune Evasion
Benjamin Ziman, Talia A. Wenger, … De‐Chen Lin·Cancer ResearchPeer-reviewed·May 19, 2026
- Serine synthesis pathway upregulated by E-cadherin is essential for the proliferation and metastasis of breast cancers
- Constraint-based modeling identifies metabolic vulnerabilities during the epithelial to mesenchymal transition
S. E. Campit, V. G. Keshamouni, S. Chandrasekaran·bioRxiv·Jan 31, 2022